Below are the most recent publications written about "Drug Monitoring" by people in Profiles.
-
Conti RM, Padula WV, Becker RV, Salamone S. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia. J Manag Care Spec Pharm. 2021 Aug; 27(8):1077-1085.
-
Di Trana A, La Maida N, Tittarelli R, Huestis MA, Pichini S, Busard? FP, Carlier J. Monitoring Prenatal Exposure to Buprenorphine and Methadone. Ther Drug Monit. 2020 04; 42(2):181-193.
-
Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busard? FP. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Ther Drug Monit. 2020 04; 42(2):205-221.
-
Carlier J, Huestis MA, Zaami S, Pichini S, Busard? FP. Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids. Ther Drug Monit. 2020 04; 42(2):194-204.
-
McEvoy JP, Kremens DE. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. J Clin Psychiatry. 2020 Jan 28; 81(1).
-
Hozack BA, Rivlin M, Graham J, Lutsky KF, Beredjiklian PK. Validation of the prescription drug monitoring program Web site. J Opioid Manag. 2019 Nov/Dec; 15(6):495-498.
-
Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. JAMA Cardiol. 2019 08 01; 4(8):756-764.
-
Hertz DL, Speth KA, Kidwell KM, Gersch CL, Desta Z, Storniolo AM, Stearns V, Skaar TC, Hayes DF, Henry NL, Rae JM. Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat. 2017 Oct; 165(3):659-668.
-
Piccini JP, Clark RL, Kowey PR, Mittal S, Dunnmon P, Stockbridge N, Reiffel JA, Turakhia MP, Ziegler PD, Kleiman RB, Ismat F, Sager P. Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium. Am Heart J. 2017 May; 187:156-169.
-
Fung S, Kwan P, Fabri M, Horban A, Pelemis M, Hann HW, Gurel S, Caruntu FA, Flaherty JF, Massetto B, Kim K, Kitrinos KM, Subramanian GM, McHutchison JG, Yee LJ, Elkhashab M, Berg T, Sporea I, Yurdaydin C, Husa P, Jablkowski MS, Gane E. Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study. J Hepatol. 2017 01; 66(1):11-18.